Fundies.
English

Segment disclosures

Company overview

NANOSTRING TECHNOLOGIES INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

7 dimension combinations 54 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Consumables · Diagnostics

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ProductOrServiceAxis=nstg:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=nstg:DiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3041000 USD20131108Open filing evidence
2013-01-01 – 2013-09-3041000 USD20140113Open filing evidence

Operating Segments · Consumables · Life Science · Product

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ProductOrServiceAxis=nstg:ConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=nstg:LifeScienceMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-304376000 USD20131108Open filing evidence
2013-01-01 – 2013-09-3012380000 USD20140113Open filing evidence
2013-04-01 – 2013-06-304305000 USD20130808Open filing evidence
2013-01-01 – 2013-06-308004000 USD20130808Open filing evidence
2012-01-01 – 2012-12-3113036000 USD20140113Open filing evidence
2012-07-01 – 2012-09-303568000 USD20131108Open filing evidence
2012-01-01 – 2012-09-309325000 USD20140113Open filing evidence
2012-04-01 – 2012-06-303054000 USD20130808Open filing evidence
2012-01-01 – 2012-06-305757000 USD20130808Open filing evidence
2011-01-01 – 2011-12-319997000 USD20140113Open filing evidence
2010-01-01 – 2010-12-315034000 USD20140113Open filing evidence

Operating Segments · Instruments · Diagnostics

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ProductOrServiceAxis=nstg:InstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=nstg:DiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30285000 USD20131108Open filing evidence
2013-01-01 – 2013-09-30488000 USD20140113Open filing evidence
2013-04-01 – 2013-06-30203000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30203000 USD20130808Open filing evidence

Operating Segments · Instruments · Life Science · Product

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:ProductOrServiceAxis=nstg:InstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=nstg:LifeScienceMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-303267000 USD20131108Open filing evidence
2013-01-01 – 2013-09-307226000 USD20140113Open filing evidence
2013-04-01 – 2013-06-302320000 USD20130808Open filing evidence
2013-01-01 – 2013-06-303959000 USD20130808Open filing evidence
2012-01-01 – 2012-12-318786000 USD20140113Open filing evidence
2012-07-01 – 2012-09-302183000 USD20131108Open filing evidence
2012-01-01 – 2012-09-306262000 USD20140113Open filing evidence
2012-04-01 – 2012-06-302579000 USD20130808Open filing evidence
2012-01-01 – 2012-06-304079000 USD20130808Open filing evidence
2011-01-01 – 2011-12-317112000 USD20140113Open filing evidence
2010-01-01 – 2010-12-316472000 USD20140113Open filing evidence

Operating Segments · Diagnostics

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=nstg:DiagnosticsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30326000 USD20131108Open filing evidence
2013-01-01 – 2013-09-30529000 USD20140113Open filing evidence
2013-04-01 – 2013-06-30203000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30203000 USD20130808Open filing evidence

Operating Segments · Life Science

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=nstg:LifeScienceMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-308063000 USD20131108Open filing evidence
2013-01-01 – 2013-09-3020754000 USD20140113Open filing evidence
2013-04-01 – 2013-06-307015000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3012691000 USD20130808Open filing evidence
2012-01-01 – 2012-12-3122973000 USD20140113Open filing evidence
2012-07-01 – 2012-09-306035000 USD20131108Open filing evidence
2012-01-01 – 2012-09-3016480000 USD20140113Open filing evidence
2012-04-01 – 2012-06-305943000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3010445000 USD20130808Open filing evidence
2011-01-01 – 2011-12-3117800000 USD20140113Open filing evidence
2010-01-01 – 2010-12-3111730000 USD20140113Open filing evidence

Operating Segments · Life Science · Service

Consolidation Items · Statement Business Segments · Subsegments Consolidation Items

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=nstg:LifeScienceMember;us-gaap:SubsegmentsConsolidationItemsAxis=nstg:ServiceMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30420000 USD20131108Open filing evidence
2013-01-01 – 2013-09-301148000 USD20140113Open filing evidence
2013-04-01 – 2013-06-30390000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30728000 USD20130808Open filing evidence
2012-01-01 – 2012-12-311151000 USD20140113Open filing evidence
2012-07-01 – 2012-09-30284000 USD20131108Open filing evidence
2012-01-01 – 2012-09-30893000 USD20140113Open filing evidence
2012-04-01 – 2012-06-30310000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30609000 USD20130808Open filing evidence
2011-01-01 – 2011-12-31691000 USD20140113Open filing evidence
2010-01-01 – 2010-12-31224000 USD20140113Open filing evidence